Interested in pursuing Postgraduate GMP qualifications in 2027? Applications to join our next cohort in March 2027 close soon?
SeerPharma
Recent Posts
Beyond the Lab: Career Pathways in Pharmaceuticals and Biotechnology
SeerPharma and the University of Technology Sydney (UTS) invite you to an informative careers session exploring opportunities across the pharmaceutical, biotechnology, medical device and broader life sciences industries.
Webinar | Why E-Logbooks Matter
Paper logbooks are still everywhere on GMP manufacturing floors. They do the job, but they cost more than most sites realise.
AI is Not Your Quality Manager: FDA Warning for Pharma and Device
Artificial intelligence is rapidly becoming part of everyday quality and regulatory activities. It can help draft procedures and specifications, generate risk management documentation, and create quality records. The numerous AI tools available can significantly improve efficiency.
Webinar | KompetencyAI: Measuring Real Competence, Not Just Knowledge
Training has always been important in regulated industries, especially for those involved in the manufacture and handling of pharmaceuticals, medical devices and healthcare products.
Harness the Power of AI in GxP: SeerPharma Joins KENX Singapore 2026
Artificial Intelligence is rapidly transforming the life sciences industry. But how can organisations harness its potential while maintaining the quality, compliance and control expected within a regulated GxP environment?
AI Adoption: Why Risk and Control matters in GxP Industries
Artificial intelligence is becoming ubiquitous, with organisations using it to improve productivity, analyse information faster, support decision-making, and find new ways of working.
Webinar | Transforming Internal Audits into a Strategic Asset
In the medical device industry, internal audits are often viewed primarily as a regulatory requirement. ISO 13485:2016 requires organisations to assess the effectiveness of their Quality Management System (QMS). However, organisations that treat internal auditing purely as a compliance exercise risk missing a significant opportunity.
SeerPharma to Support the BioMelbourne Network BioSymposium 2026
The BioMelbourne Network is Victoria's leading industry association representing organisations across biotechnology, medical technology, and health innovation. As the peak industry body, it brings together researchers, industry leaders, government, and investors to advance one of Australia's most dynamic life sciences ecosystems.
